Browse by author
Lookup NU author(s): Dr Malcolm Brodlie
This work is licensed under a Creative Commons Attribution 4.0 International License (CC BY 4.0).
© 2020 The Authors. We report the first case of biodegradable airway stent insertion for a patient with bronchomalacia and cystic fibrosis (CF). This female infant with antenatally diagnosed cystic fibrosis developed respiratory distress by three weeks of age. On lower airway examination she was found to have severe left main stem bronchomalacia causing left upper lobe hyperinflation and subsequent right upper lobe collapse. By eight weeks of age she developed life-threatening respiratory failure requiring high pressure invasive ventilation. A biodegradable bronchial stent was inserted to the left main bronchus at thirteen weeks of age with successful extubation from invasive respiratory support four days later. A second biodegradable stent was inserted nine weeks later, due to persistent bronchomalacia following stent degradation and redevelopment of oxygen requirement. She was discharged home off all respiratory support eight weeks later and has remained well, requiring no further surgical intervention for bronchomalacia to date, now age three years.
Author(s): Harris CA, Brodlie M, O'Brien C, Thomas MF
Publication type: Article
Publication status: Published
Journal: Journal of Cystic Fibrosis
Year: 2021
Volume: 20
Issue: 2
Pages: e13-e15
Print publication date: 01/03/2021
Online publication date: 07/11/2020
Acceptance date: 23/10/2020
Date deposited: 24/05/2021
ISSN (print): 1569-1993
ISSN (electronic): 1873-5010
Publisher: Elsevier BV
URL: https://doi.org/10.1016/j.jcf.2020.10.004
DOI: 10.1016/j.jcf.2020.10.004
PubMed id: 33168477
Altmetrics provided by Altmetric